In February, Canada’s economy almost regained all of the jobs it lost in the two months prior, and the unemployment rate was the lowest it has been since March 2020.
The number of people employed in February increased by 259,000 after falling by 266,000 over December and January. Statistics Canada derived these data from conducting their monthly Labour Force Survey during the week of February 14 to 20.
Employment rates are the number of people who are working as a percentage of the population of people aged 15 and older. Unemployment is calculated by the number of unemployed people as a percentage of the entire labour force.
In February, the unemployment rate fell to 8.2 per cent, 1.2 percentage points lower than January and the lowest since Canada went into lockdown last year.
Compared with February 2020, there were 599,000 (-3.1 per cent) fewer people employed, and 406,000 (+50 per cent) more people working less than half of their usual hours. The total hours worked increased by 1.4 per cent, driven by gains in wholesale and retail trade.
Employment rebounds in industries most affected by coronavirus-related closures
The number of people working in retail trade as well as accommodation and food services increased in February as coronavirus-related measures were lifted.
Employment in the information, culture, and recreation industry was little changed in February, after several months of steady decline.
February employment increases were concentrated in low-paying jobs of $17.50 per hour or less, which reflects the growth in industries with a high proportion of low-paying jobs.
Employment gains in professional, scientific, and technical services exceed pre-pandemic levels
The number of people working in professional, scientific, and technical services was little changed month over month, but employment in the industry rose 5.6 per cent compared to the same time last year, which is equal to about 86,000 more people working. This is the largest year-over-year increase across all industries. Nearly all of these gains were seen in Ontario and British Columbia. Many businesses in this industry can operate remotely, which allows them to stay open during periods of lockdown.
For this industry, the job vacancy rate was higher than the Canadian average in December, after seeing months of employment growth in the latter part of 2020.
There are about 75,000 more people working in computer and information systems occupations compared to February 2020, including both professional and technical occupations. These year-over-year gains were driven mostly by men and were little changed among women.
Employment rates for very recent immigrants little changed
Coronavirus-related travel restrictions caused the number of newcomers in 2020 to fall to the lowest level since 1998. In February, there were 13.8 per cent fewer very recent immigrants in the labour market compared year-over-year. This group is comprised of permanent residents who landed in Canada within the past five years.
Employment for these newcomers was also down 12.1 per cent compared to the same time frame. As a result, the employment rate for very recent immigrants for the three-month period ending in February was little changed compared to the same time last year.
For immigrants who landed more than five years ago, employment in February was one per cent shy of pre-pandemic levels. Their employment rate was slightly lower than Canadian-born workers, with immigrant employment rates at 57.3 per cent, and Canadian-born workers at 58.3 per cent.
The importance of population growth and employment rate
Canada’s level of employment and employment rate will be important indicators of labour market conditions. Statistics Canada says that in order for Canada to return to pre-pandemic employment rates, the level of employment must increase beyond February 2020 to match population growth that has occurred since then.
Canada’s employment rate in February 2020 was 61.8 per cent. By April, it fell to 51.5 per cent, the lowest level since comparable data became available in 1976. This past February, the employment rate was 59.4 per cent, which is 2.4 percentage points below pre-pandemic levels.
If the population had remained the same year-over-year, the employment rate in February would have been 5.9 percentage points below the pre-pandemic rate. This difference shows the importance of population growth in economic recovery. There has been a small population increase in Canada, although reduced levels of immigrants have slowed growth. In an average year, immigration is responsible for roughly 80 per cent of Canada’s population growth.
The Canadian government committed to welcoming 401,000 new immigrants in 2021. In January alone, immigration rates were comparable to pre-pandemic levels, suggesting that Canada is on track to meet its ambitious immigration levels target.
© CIC News All Rights Reserved. Visit CanadaVisa.com to discover your Canadian immigration options.
CANADA STOCKS – TSX falls 0.14% to 19,201.28
* The Toronto Stock Exchange’s TSX falls 0.14 percent to 19,201.28
* Leading the index were Stantec Inc <STN.TO>, up 3.4%, Imperial Oil Ltd, up 3.3%, and Corus Entertainment Inc, higher by 2.9%.
* Lagging shares were Aphria Inc, down 14.2%, Village Farms International Inc, down 9.9%, and Aurora Cannabis Inc, lower by 9.4%.
* On the TSX 91 issues rose and 134 fell as a 0.7-to-1 ratio favored decliners. There were 24 new highs and no new lows, with total volume of 228.0 million shares.
* The most heavily traded shares by volume were Toronto-dominion Bank, Royal Bank Of Canada and Suncor Energy Inc.
* The TSX’s energy group fell 0.32 points, or 0.3%, while the financials sector climbed 2.46 points, or 0.7%.
* West Texas Intermediate crude futures rose 0.52%, or $0.31, to $59.63 a barrel. Brent crude rose 0.4%, or $0.25, to $63.2 [O/R]
* The TSX is up 10.1% for the year.
Air Canada signs C$5.9 billion government aid package, agrees to buy Airbus, Boeing jets
By David Ljunggren and Allison Lampert
OTTAWA/MONTREAL (Reuters) -Air Canada, struggling with a collapse in traffic due to the COVID-19 pandemic, reached a deal on Monday on a long-awaited aid package with the federal government that would allow it to access up to C$5.9 billion ($4.69 billion) in funds.
The agreement – the largest individual coronavirus-related loan that Ottawa has arranged with a company – was announced after the airline industry criticized Prime Minister Justin Trudeau’s Liberal government for dawdling. The United States and France acted much more quickly to help major carriers.
Canada‘s largest carrier, which last year cut over half its workforce, or 20,000 jobs, and other airlines have been negotiating with the government for months on a coronavirus aid package.
In February, Air Canada reported a net loss for 2020 of C$4.65 billion, compared with a 2019 profit of C$1.48 billion.
As part of the deal, Air Canada agreed to ban share buybacks and dividends, cap annual compensation for senior executives at C$1 million a year and preserve jobs at the current level, which is 14,859.
It will also proceed with planned purchases of 33 Airbus SE 220 airliners and 40 Boeing Co 737 MAX airliners.
Chris Murray, managing director, equity research at ATB Capital Markets, said the deal took into account the “specific needs of Air Canada in the short and medium term without being overly onerous.”
He added: “It gives them some flexibility in drawing down additional liquidity as needed.”
Transport Minister Omar Alghabra said the government was still in negotiations with other airlines about possible aid.
Canada, the world’s second-largest nation by area, depends heavily on civil aviation to keep remote communities connected.
Opposition politicians fretted that further delays in announcing aid could result in permanent damage to the country.
Air Canada said it would resume services on nearly all of the routes it had suspended because of COVID-19.
‘SIGNIFICANT LAYER OF INSURANCE’
The deal removes a potential political challenge for the Liberals, who insiders say are set to trigger an election later this year.
The government has agreed to buy C$500 million worth of shares in the airline, at C$23.1793 each, or a 14.2% discount to Monday’s close, a roughly 6% stake.
“Maintaining a competitive airline sector and good jobs is crucially important,” Finance Minister Chrystia Freeland told reporters, adding the equity stake would allow taxpayers to benefit when the airline’s fortunes recovered.
The Canadian government previously approved similar loans for four other companies worth up to C$1.billion, including up to C$375 million to low-cost airline Sunwing Vacations Inc. The government has paid out C$73.47 billion under its wage subsidy program and C$46.11 billion in loans to hard-hit small businesses.
Michael Rousseau, Air Canada‘s president and chief executive officer, said the liquidity “provides a significant layer of insurance for Air Canada.”
Jerry Dias, head of the Unifor private-sector union, described the announcement as “a good deal for everybody.”
Unifor represents more than 16,000 members working in the air transportation sector.
But the Canadian Union of Public Employees, which represents roughly 10,000 Air Canada flight attendants, said the package protected the jobs of current workers rather than the 7,500 members of its union who had been let go by the carrier.
($1=1.2567 Canadian dollars)
(Reporting by David Ljunggren in Ottawa and Allison Lampert in Montreal; Additional reporting by Julie Gordon in Ottawa and Munsif Vengattil in Bengaluru; Editing by Dan Grebler and Peter Cooney)
U.K. advises limiting AstraZeneca in under-30s amid clot worry
British authorities recommended Wednesday that the AstraZeneca COVID-19 vaccine not be given to adults under 30 where possible because of strengthening evidence that the shot may be linked to rare blood clots.
The recommendation came as regulators both in the United Kingdom and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people — even though the European Medicines Agency said it had found a “possible link” between the shot and the rare clots. British authorities recommended that people under 30 be offered alternatives to AstraZeneca. But the EMA advised no such age restrictions, leaving it up to its member-countries to decide whether to limit its use.
Several countries have already imposed limits on who can receive the vaccine, and any restrictions are closely watched since the vaccine, which is cheaper and easier to store than many others, is critical to global immunization campaigns and is a pillar of the UN-backed program known as COVAX that aims to get vaccines to some of the world’s poorest countries.
“This is a course correction, there’s no question about that,” Jonathan Van-Tam, England’s deputy chief medical officer, said during a press briefing. “But it is, in a sense, in medicine quite normal for physicians to alter their preferences for how patients are treated over time.”
Van-Tam said the effect on Britain’s vaccination timetable — one of the speediest in the world — should be “zero or negligible,” assuming the National Health Service receives expected deliveries of other vaccines, including those produced by Pfizer and Moderna.
EU and U.K. regulators held simultaneous press conferences Wednesday afternoon to announce the results of investigations into reports of blood clots that sparked concern about the rollout of the AstraZeneca vaccine.
The EU agency described the clots as “very rare” side effects. Dr Sabine Straus, chair of EMA’s Safety Committee, said the best data is coming from Germany where there is one report of the rare clots for every 100,000 doses given, although she noted far fewer reports in the U.K. Still, that’s less than the clot risk that healthy women face from birth control pills, noted another expert, Dr. Peter Arlett.
The agency said most of the cases reported have occurred in women under 60 within two weeks of vaccination — but based on the currently available evidence, it was not able to identify specific risk factors. Experts reviewed several dozen cases that came mainly from Europe and the U.K., where around 25 million people have received the AstraZeneca vaccine.
“The reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine,” said Emer Cooke, the agency’s executive director. “The risk of mortality from COVID is much greater than the risk of mortality from these side effects.”
Arlett said there is no information suggesting an increased risk from the other major COVID-19 vaccines.
The EMA’s investigation focused on unusual types of blood clots that are occurring along with low blood platelets. One rare clot type appears in multiple blood vessels and the other in veins that drain blood from the brain.
While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced” among younger people who are less likely to become seriously ill with COVID-19, the U.K’s Van-Tam said.
“We are not advising a stop to any vaccination for any individual in any age group,” said Wei Shen Lim, who chairs Britain’s Joint Committee on Vaccination and Immunization. “We are advising a preference for one vaccine over another vaccine for a particular age group, really out of the utmost caution rather than because we have any serious safety concerns.”
In March, more than a dozen countries, mostly in Europe, suspended their use of AstraZeneca over the blood clot issue. Most restarted — some with age restrictions — after the EMA said countries should continue using the potentially life-saving vaccine.
Britain, which relies heavily on AstraZeneca, however, continued to use it.
The suspensions were seen as particularly damaging for AstraZeneca because they came after repeated missteps in how the company reported data on the vaccine’s effectiveness and concerns over how well its shot worked in older people. That has led to frequently changing advice in some countries on who can take the vaccine, raising worries that AstraZeneca’s credibility could be permanently damaged, spurring more vaccine hesitancy and prolonging the pandemic.
Dr. Peter English, who formerly chaired the British Medical Association’s Public Health Medicine Committee, said the back-and-forth over the AstraZeneca vaccine globally could have serious consequences.
“We can’t afford not to use this vaccine if we are going to end the pandemic,” he said.
In some countries, authorities have already noted hesitance toward the AstraZeneca shot.
“People come and they are reluctant to take the AstraZeneca vaccine, they ask us if we also use anything else,” said Florentina Nastase, a doctor and co-ordinator at a vaccination centre in Bucharest, Romania. “There were cases in which people (scheduled for the AstraZeneca) didn’t show up, there were cases when people came to the centre and saw that we use only AstraZeneca and refused (to be inoculated).”
Meanwhile, the governor of Italy’s northern Veneto region had said earlier Wednesday that any decision to change the guidance on AstraZeneca would cause major disruptions to immunizations — at a time when Europe is already struggling to ramp them up — and could create more confusion about the shot.
“If they do like Germany, and allow Astra Zeneca only to people over 65, that would be absurd. Before it was only for people under 55. Put yourself in the place of citizens, it is hard to understand anything,” Luca Zaia told reporters.
The latest suspension of AstraZeneca came in Spain’s Castilla y Leon region, where health chief Veronica Casado said Wednesday that “the principle of prudence” drove her to put a temporary hold on the vaccine that she still backed as being both effective and necessary.
French health authorities had said they, too, were awaiting EMA’s conclusions, as were some officials in Asia.
On Wednesday, South Korea said it would temporarily suspend the use of AstraZeneca’s vaccine in people 60 and younger. In that age group, the country is only currently vaccinating health workers and people in long-term care settings.
The Korea Disease Control and Prevention Agency said it would also pause a vaccine rollout to school nurses and teachers that was to begin on Thursday, while awaiting the outcome of the EMA’s review.
But some experts urged perspective. Prof Anthony Harnden, the deputy chair of Britain’s vaccination committee, said that the program has saved at least 6,000 lives in the first three months and will help pave the way back to normal life.
“What is clear it that for the vast majority of people the benefits of the Oxford AZ vaccine far outweigh any extremely small risk,” he said. “And the Oxford AZ vaccine will continue to save many from suffering the devastating effects that can result from a COVID infection.”
Source: – CTV News
Canada will not restrict AstraZeneca COVID-19 vaccine, says benefits outweigh risk
Canadian retail titan W. Galen Weston dies at 80
Factbox-Some countries limit AstraZeneca vaccine use, US pauses J&J shot
Silver investment demand jumped 12% in 2019
Iran anticipates renewed protests amid social media shutdown
Europe kicks off vaccination programs | All media content | DW | 27.12.2020 – Deutsche Welle
News13 hours ago
Canadian crude imports fall 20% in 2020 due to COVID-19 pandemic
News12 hours ago
Canada’s migrant farmworkers remain at risk a year into pandemic
Health12 hours ago
Factbox-Some countries limit AstraZeneca vaccine use, US pauses J&J shot
News14 hours ago
Air Canada shares close marginally lower after government takes equity stake
News14 hours ago
Novavax CFO Greg Covino to step down
Economy12 hours ago
Canada to go big on budget spending as pandemic lingers, election looms
News14 hours ago
Canada scraps export permits for drone technology to Turkey
News11 hours ago
Canadian retail titan W. Galen Weston dies at 80